The 36-month beta value for OGEN is at 1.15. Analysts have varying views on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 1 as “hold,” and 0 as “sell.”
The public float for OGEN is 17.11M, and currently, shorts hold a 1.83% of that float. The average trading volume for OGEN on April 03, 2025 was 5.01M shares.
OGEN) stock’s latest price update
The stock price of Oragenics Inc (AMEX: OGEN) has dropped by -5.84 compared to previous close of 0.21. Despite this, the company has seen a fall of -18.81% in its stock price over the last five trading days. globenewswire.com reported 2025-03-27 that ONP-002 Advances Toward Phase IIa Concussion Trial with Strengthened Financial Foundation and Industry Momentum ONP-002 Advances Toward Phase IIa Concussion Trial with Strengthened Financial Foundation and Industry Momentum
OGEN’s Market Performance
Oragenics Inc (OGEN) has seen a -18.81% fall in stock performance for the week, with a -25.94% decline in the past month and a -53.73% plunge in the past quarter. The volatility ratio for the week is 8.89%, and the volatility levels for the past 30 days are at 7.71% for OGEN. The simple moving average for the past 20 days is -21.82% for OGEN’s stock, with a -64.55% simple moving average for the past 200 days.
OGEN Trading at -27.28% from the 50-Day Moving Average
After a stumble in the market that brought OGEN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -94.17% of loss for the given period.
Volatility was left at 7.71%, however, over the last 30 days, the volatility rate increased by 8.89%, as shares sank -28.58% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -30.59% lower at present.
During the last 5 trading sessions, OGEN fell by -18.81%, which changed the moving average for the period of 200-days by -88.17% in comparison to the 20-day moving average, which settled at $0.2557. In addition, Oragenics Inc saw -45.87% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at OGEN starting from DUNTON ALAN W, who sale 66 shares at the price of $0.36 back on Dec 06 ’24. After this action, DUNTON ALAN W now owns 25,623 shares of Oragenics Inc, valued at $24 using the latest closing price.
Telling Fred, the Director of Oragenics Inc, sale 3,597 shares at $0.36 during a trade that took place back on Dec 06 ’24, which means that Telling Fred is holding 34,748 shares at $1,295 based on the most recent closing price.
Stock Fundamentals for OGEN
The total capital return value is set at 49.83. Equity return is now at value -714.95, with -328.26 for asset returns.
Based on Oragenics Inc (OGEN), the company’s capital structure generated 2.82 points at debt to capital in total, while cash flow to debt ratio is standing at -26.17. The debt to equity ratio resting at -1.55. The interest coverage ratio of the stock is -353.99.
Currently, EBITDA for the company is -10.56 million with net debt to EBITDA at 0.05. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.87.
Conclusion
In conclusion, Oragenics Inc (OGEN) has had a bad performance lately. Opinion on the stock among analysts is mixed, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
